Apogenix

Developer of novel protein therapeutics for the treatment of cancer and inflammatory diseases

placeHeidelberg, Baden-wurttemberg, Germany calendar_todayFounded 2005 groups57 employees language apogenix.com

Registered entities

Innovation

26 patent families (11 granted) — focus: Chemistry & metallurgy, Physics & computing, Human necessities, Operations & transport; filing pace slowing. Cited 829 times.

YearFilings
20124
20135
201410
201512
20169
20177
20181
20191
20203
20213
20231

Investor mix

5 investors on record; lead investors include Dievini.

Investor typeCountShare
Venture capital120%
Other / undisclosed480%
Coming soon